ARDT — ARDENT HEALTH PA

Ownership history in MARSHALL WACE, LLP  ·  3 quarters on record

This page tracks every 13F SEC filing in which MARSHALL WACE, LLP reported a position in ARDENT HEALTH PA (ARDT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 26,594 +15,845 +147.4% 0.00% $352K $13.25
2025 Q2 REDUCED 10,749 -33,282 -75.6% 0.00% $147K $13.66
2024 Q3 INITIATED 44,031 — — 0.00% $809K $18.38
% of Fund (quarterly)    ARDT price (monthly, adj. close)

Other funds also holding ARDT

As of 2025 Q4 — sorted by position size

Ventas, Inc. 100.0% CHAI TRUST CO LLC 3Y 7Y 58.78% GOLDENTREE ASSET MANAGEMENT LP 3Y 7Y 1.1% DENALI ADVISORS LLC 3Y 7Y 0.24% CastleKnight Management LP 3Y 0.23% SageView Advisory Group, LLC 3Y 0.19% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.18% PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 3Y 7Y 0.1% PEREGRINE CAPITAL MANAGEMENT LLC 3Y 7Y 0.08% Numerai GP LLC 3Y 0.07%
← Back to MARSHALL WACE, LLP Holdings